Trial Details

RECRUITING
Basic Information
Clinical ID c453
Identifier NCT06597916
Trial Title RSV Vaccination in Immunocompromised Patients.
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions RSV Infection
Interventions BIOLOGICAL: Arexvy powder and suspension for injection
Participant Information
Sponsor Medical University of Vienna
City Vienna
Country/Region Austria
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2024-09-19
Primary Completion Date 2025-08-31
Completion Date 2026-03-31